Science Center

Taurus Vascular is a medical device company dedicated to enhancing long-term outcomes for patients with aortic aneurysms. The company is focused on developing innovative technology aimed at transforming the standard of care for these patients. Its novel medical device is designed to eliminate the adverse effects of endoleaks and promote accelerated shrinkage of aneurysm sacs following endovascular aortic aneurysm repair (EVAR). By addressing these critical issues, Taurus Vascular aims to improve patient outcomes within the healthcare industry.

AB Fertitlity develops products for reproductive medicine.

EmpiricaLab is an online learning platform tailored for healthcare teams, emphasizing last-mile training and collaborative authoring. The platform facilitates peer learning by allowing users to discover, create, and curate work-relevant content that enhances onboarding and productivity. By integrating learning directly into the work environment, EmpiricaLab supports knowledge transfer and collaboration among team members. This approach helps clients accelerate their digital transformation efforts by fostering a culture of continuous improvement and skill development within healthcare organizations.

MTDS promotes health and wellness by providing services that mitigate the workload of its fellow medical institutions as well as providing resources to the community.

Steradian Technologies is building a 30-second COVID-19 detection test. It uses focal point projection systems to recreate human eyesight and use photonics to detect pathogens in 30-seconds.

Houston-based medical device startup Prana Thoracic, Inc. is dedicated to developing solutions for early intervention in lung cancer. We are an experienced team of surgeons, engineers and entrepreneurs on a mission to tackle lung cancer; the #1 cancer killer in the US. The paradigm of screening, detection, and early intervention that has been deployed in other major cancers has so far eluded lung cancer. As a result, only 16% of lung cancers are found at an early stage and the current 5-year survival rate is < 20%. Recent changes to lung cancer screening guidelines have illuminated a path to improving outcomes in lung cancer. However, these advances rely on excising suspicious nodules and providing sufficient tissue for definitive diagnosis. We believe this is the missing piece of the puzzle, and physicians need a new generation of surgical oncology tools for lung cancer. Prana Thoracic plans to revolutionize the early diagnosis and treatment of lung cancer by making it easier and less invasive to deal with the rapidly growing number of early suspicious lung nodules; ensuring that we do not miss the window of opportunity to intervene early.

BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.

Trace Orthopedics specializes in innovative medical devices aimed at tendon reattachment without the need for surgery. The company has developed a minimally invasive procedure that utilizes a needle to insert a screw and wire coil implant, allowing for the repair of partially torn tendons directly to bone. This technique is designed to be performed without general anesthesia or the need for an operating room, facilitating a quicker recovery for patients and reducing overall healthcare costs. Through these advancements, Trace Orthopedics is transforming the approach to tendon injuries, making treatment more accessible and efficient.

Early skin health monitoring and care management system for wound care, dermatology, and cosmetics with initial application to the prevention of bedsores and diabetic foot ulcers. Mission: Rubitection's mission is to be the global standard system for skin health monitoring and care management for wounds and chronic dermatological skin conditions. Products: Rubitection's low cost easy to use hand held system that empowers anyone to monitor the health of their skin to identify a range of conditions early including bedsores, diabetic foot ulcers, vascular leg ulcers and chronic dermatological conditions.

Aware.ai uses AI to create virtual support communities for women and connect them to resources during pregnancy.

Opal HTM is a company focused on enhancing hospital safety and efficiency through innovative medical equipment management solutions. It has developed a healthcare equipment inventory management platform that aims to maximize the return on investment in technology. By optimizing procurement and maintenance strategies, Opal HTM helps healthcare managers improve workflows and plan effectively for the future. The platform provides unprecedented clarity, allowing for better management of equipment inventories, which ultimately enhances the overall effectiveness and efficiency of healthcare operations.

Gray Oncology Solutions is focused on enhancing the oncology treatment process through innovative healthcare resource allocation software. The company aims to optimize the efficiency of cancer centers by developing a comprehensive operating system that streamlines workflows across various oncological interventions. This software automates patient scheduling and addresses the complexities of multi-disciplinary care, which allows healthcare providers to improve access to treatment, minimize patient wait times, and enhance both patient and staff satisfaction. By prioritizing personalized treatment journeys and statistically optimizing clinical outcomes, Gray Oncology Solutions ultimately strives to deliver superior patient care in the field of oncology.

Allevi develops innovative tools for designing and engineering 3D tissues, focusing on bioprinting technology. The company offers desktop 3D bioprinters that allow users to create functional three-dimensional living tissues using various biomaterials and cell lines. Additionally, Allevi provides bioinks made from collagen and hyaluronic acid, which are available for purchase online. Their cloud-based platform, Bioprint Online, enables users to design complex structures, define materials, and monitor the printing process. Allevi's products serve a diverse clientele, including researchers in tissue engineering, regenerative medicine, and cell biology, as well as industrial and pharmaceutical companies for drug testing and development, and educators. Established in 2014 and based in Philadelphia, Pennsylvania, Allevi was formerly known as BioBots, Inc.

StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.